About Neon Laboratories Limited
Data last updated:
Neon Laboratories Limited is a public limited company based in Mumbai, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 22 June 1982 and has been in existence for over 44 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24100MH1982PLC027493. Its GSTIN is 27AAACN1299D1ZK (Maharashtra).
The company has an authorised share capital of ₹9.75 Cr and a paid-up capital of ₹9.72 Cr. It was formerly known as Neon Laboratories Private Limited. It is led by directors including Uttamchand Kesharimal Jain (Whole-Time Director) and Ashokkumar Keshrimal Jain (Whole-Time Director).
Its last annual general meeting (AGM) was held on 22 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 140 Damji Shamji Ind Compmahakali Caves Road Andheri(E), Mumbai, Maharashtra, India – 400093.
As per the financials filed for FY 2025, the company reported a revenue of ₹1,222.81 Cr, a growth of 4% compared to the previous year. For the same year it recorded a net profit of ₹179.79 Cr (net margin 14.7%) and EBITDA of ₹270.89 Cr (EBITDA margin 22.2%). Revenue has grown at a compounded annual rate (CAGR) of 12% over three years and 9% over five years.
The company has about 2,185 employees on its provident fund (EPFO) records. Its group structure includes 3 subsidiaries.
As per MCA filings, the company has open charges of ₹104.5 Cr and satisfied charges of ₹824.17 Cr on record. Court records list 179 cases involving the company, including 121 filed by the company and 58 filed against it; 44 cases are pending. The company has 4 deals on record (4 secondary share transfers); the latest was in May 2024. Its 8 peer companies in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 3 larger and 5 smaller; the largest is Sentiss Pharma Private Limited with revenue of ₹1,262.74 Cr.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website neongroup.com.
Company details
Contact details
Neon Laboratories Limited's registered office is in Mumbai, Maharashtra. Its website is neongroup.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered Address140 Damji Shamji Ind Compmahakali Caves Road Andheri(E), Mumbai, Maharashtra, India – 400093
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Neon Laboratories Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Neon Laboratories is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Neon Laboratories Limited, buy the company report.
Financials of Neon Laboratories Limited
FY 2025 filings availableNeon Laboratories Limited reported revenue of ₹1,222.81 Cr (up 4% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 9% over five years, including 4% growth in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹270.89 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹179.79 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 22.2% | ||||
| Net Profit Margin | 14.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Neon Laboratories Limited, buy the company report.
Board of directors of Neon Laboratories Limited
Neon Laboratories has 7 current directors and 10 former directors. Current directors are listed first, with their designation and appointment date.
Peer comparison
Neon Laboratories Limited is compared with the 8 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Sentiss Pharma Private Limited | ₹1,262.74 Cr (FY 2025) | 43.0% | New Delhi, Delhi, India | |||
| Innova Captab Limited | ₹1,255.72 Cr (FY 2025) | 15.0% | Thane, Maharashtra, India | |||
| Cipla Health Limited | ₹1,228.87 Cr (FY 2025) | 17.0% | Mumbai, Maharashtra, India | |||
| Neon Laboratories Limitedthis company | ₹1,222.81 Cr (FY 2025) | ₹179.79 Cr | 14.7% | 4.0% | 2,185 | Mumbai, Maharashtra, India |
| Corona Remedies Limited | ₹1,202.35 Cr (FY 2025) | 18.0% | Ahmedabad, Gujarat, India | |||
| Hetero Healthcare Limited | ₹1,189.8 Cr (FY 2025) | 16.0% | Hyderabad, Telangana, India | |||
| BDR Pharmaceuticals International Private Limited | ₹1,137.31 Cr (FY 2025) | 2.0% | Mumbai, Maharashtra, India | |||
| Tirupati Medicare Limited | ₹1,119.15 Cr (FY 2025) | 6.0% | New Delhi, Delhi, India | |||
| Zuventus Healthcare Limited | ₹1,117.95 Cr (FY 2025) | 4.0% | Pune, Maharashtra, India |
To see the full peer comparison of Neon Laboratories Limited, buy the company report.
Auditor
Neon Laboratories Limited is audited by JANAK MAJETHIA & ASSOCIATRS for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| JANAK MAJETHIA & ASSOCIATRS | FY 2024 | 104037W |
Shareholding
The shareholding of Neon Laboratories Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Neon Laboratories Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 30 Aug 2023 | 100799370 | State Bank of India | ₹75 Cr | Open | |
| 14 Oct 2021 | 100491750 | Standard Chartered Bank | ₹4.5 Cr | Open | |
| 06 Oct 2021 | 100493510 | State Bank of India | ₹25 Cr | Open | |
| 23 Aug 2018 | 100212072 | Others | ₹15 Lakh | Satisfied | |
| 24 Jul 2018 | 100197668 | Others | ₹56 Lakh | Satisfied |
To see the full charge records of Neon Laboratories Limited, buy the company report.
Total charge records: 33 View all charges
Deals & funding
Neon Laboratories Limited has 4 deals on record (4 secondary share transfers); the latest was in May 2024.
Deals on record (4 of 4)
| When | Deal | Amount | Parties |
|---|---|---|---|
| May 2024 | Secondary share transfer | Undisclosed | Seller: 4 individuals |
| Dec 2022 | Secondary share transfer | Undisclosed | Seller: 4 individuals |
| Sep 2018 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: Hira Pravin Jain & Hira & Co |
| Mar 2018 | Secondary share transfer | Undisclosed | Buyer: Pravin K Jain HUF, 3 individuals Seller: Babulal K Jain HUF, 3 individuals |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Neon Laboratories Limited has 179 court cases on record: 121 filed by Neon Laboratories, 58 filed against it. 44 cases are pending and 135 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 120 | 25 | 32 |
| District courts | 32 | 17 | 8 |
| Supreme Court | 16 | 10 | 1 |
| NCLAT | 7 | 3 | 3 |
| NCLT | 4 | 3 | 0 |
Cases on record (5 of 179)
| Court | Type of case | Party | Status |
|---|---|---|---|
| NCLAT, NCLAT New Delhi | Interim or miscellaneous application | Filed against the company by Vistra Itcl India Limited & Ors and 2 others | Pending |
| High Court of Delhi | Court case (C.O. (COMM.IPD-TM)) | Filed against the company by Gufic Biosciences Limited | Pending |
| Bombay High Court | Interim or miscellaneous application | Filed by the company against Effion Bio Pharma Pvt Ltd | Pending |
| Bombay High Court | Court case (LPETN) | Filed by the company against Effion Bio Pharma Pvt Ltd | Pending |
| Bombay High Court | Court case (COMIP) | Filed by the company against Effion Bio Pharma Pvt Ltd | Pending |
To see the full case history of Neon Laboratories Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Credit ratings & regulatory alerts
Neon Laboratories Limited was last rated by Crisil on 30 Jul 2020.
| Rating agency | Rated on | Rating |
|---|---|---|
| Crisil | 30 Jul 2020 |
To see the full credit ratings and regulatory alerts of Neon Laboratories Limited, buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Neon Laboratories Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Group structure & subsidiaries
Neon Laboratories has 3 subsidiary companies. This group structure data is as of FY 2024. The table lists each entity with its relationship and holding.
| Company Name | CIN | Shares held |
|---|---|---|
| VHB Medi Sciences Limited | U24232MH2007PLC174054 | |
| Korten Pharmaceuticals Private Limited | U24239MH1990PTC058797 | |
| VHB Life Sciences Limited | U74900MH2007PLC171648 |
To see the full group structure of Neon Laboratories Limited, buy the company report.
Employees & EPFO
Neon Laboratories Limited has a workforce of 2,185 employees on its EPFO records as of Mar 05, 2025, across 1 active EPFO establishment.
GST
Neon Laboratories has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAACN1299D1ZK | Maharashtra | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Neon Laboratories Limited, buy the company report.
Recent activity
Neon Laboratories Limited has 16 board changes on record since 1982: 7 appointments and 9 cessations. The latest: Pravin Keshrimal Jain ceased to be Director on 31 Mar 2025.
79 earlier events are in the company report.
Frequently asked questions
Neon Laboratories is an active public limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 22 June 1982 (44+ years old) and is registered under CIN U24100MH1982PLC027493.
Neon Laboratories has 7 current directors:
- Uttamchand Kesharimal Jain - Whole-Time Director
- Ashokkumar Keshrimal Jain - Whole-Time Director
- Abhay Uttamchand Jain - Whole-Time Director
- Pravin Keshrimal Jain - Whole-Time Director
- Siddharth Bhikchand Bhansali - Additional Director
- Hitesh Kiran Kumar - Director
- Hemali Pankaj Lodha - Additional Director
The latest financial statements of Neon Laboratories on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 22 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Neon Laboratories is 27AAACN1299D1ZK, registered in Maharashtra.
The CIN (Corporate Identification Number) of Neon Laboratories is U24100MH1982PLC027493. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Neon Laboratories has 179 court cases on record: 121 filed by the company and 58 filed against it. 44 are pending. Most are in the high courts.
Neon Laboratories was incorporated on 22 June 1982, making it 44+ years old. It is registered with the Registrar of Companies, Mumbai.
Neon Laboratories has 4 deals on record (4 secondary share transfers); the latest was in May 2024.
The peers of Neon Laboratories by revenue are Sentiss Pharma Private Limited, Innova Captab Limited, Cipla Health Limited, Corona Remedies Limited, Hetero Healthcare Limited and 3 more, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Pravin Keshrimal Jain ceased to be Director on 31 Mar 2025. Uttamchand Kesharimal Jain ceased to be Director on 31 Mar 2025. Hemali Pankaj Lodha was appointed as Additional Director on 17 Mar 2025. Neon Laboratories has 16 board changes on record in total.
Neon Laboratories can be reached through the website neongroup.com. Its registered office is in Mumbai, Maharashtra, India.